Stockscreener 앱 받기
6.08
0.33%
-0.02
시간 외 거래:
6.08
전일 마감가:
$6.10
열려 있는:
$6.15
하루 거래량:
14,985
Relative Volume:
0.26
시가총액:
$101.69M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-6.2041
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
-0.16%
1개월 성능:
+1.33%
6개월 성능:
-10.98%
1년 성능:
-3.18%
1일 변동 폭
$5.87
$6.23
1주일 범위
$5.87
$6.50
52주 변동 폭
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
명칭
Coya Therapeutics Inc
전화
650.739.3939
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
COYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.08 | 107.04M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | D. Boral Capital | Buy |
Coya Therapeutics Inc 주식(COYA)의 최신 뉴스
Intrinsic Value of Coya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedAI Volatility Forecast and Risk Monitor - Newser
Coya Therapeutics COYA Q2 2025 Earnings Preview Upside Potential on Promising Product Pipeline - AInvest
Understanding Coya Therapeutics Inc.’s price movementBuy Candidate Summary Based on Fundamentals - Newser
What drives Coya Therapeutics Inc. stock priceLightning-fast capital gains - Jammu Links News
Does Coya Therapeutics Inc. stock perform well during market downturnsTrack top-performing stocks in real-time - Jammu Links News
How does Coya Therapeutics Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? - MSN
Is it the right time to buy Coya Therapeutics Inc. stockGet daily updates on top-performing stocks - Jammu Links News
How many analysts rate Coya Therapeutics Inc. as a “Buy”Explosive earnings growth - Jammu Links News
Sector ETF performance correlation with Coya Therapeutics Inc.Buy and Exit Strategy Based on Momentum - newser.com
How strong is Coya Therapeutics Inc. company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Coya Therapeutics Inc. stock higher in 2025Overwhelming financial success - Jammu Links News
What institutional investors are buying Coya Therapeutics Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
Is Coya Therapeutics Inc. a growth stock or a value stockTremendous growth opportunities - Jammu Links News
What are the technical indicators suggesting about Coya Therapeutics Inc.Get insider insights into market trends - Jammu Links News
What are Coya Therapeutics Inc. company’s key revenue driversCapitalize on emerging trends for profits - Jammu Links News
Is Coya Therapeutics Inc. stock ready for a breakoutReal Market Tracker with Price Action Tools - Newser
Should you wait for a breakout in Coya Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
Using Python tools to backtest Coya Therapeutics Inc. strategiesMachine Learning Stock Price Forecast Tool - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionTrade Safety Matrix for Conservative Traders - Newser
Strategies to average down on Coya Therapeutics Inc.Chart Based Entry Tool for ROI Traders - Newser
How to manage a losing position in Coya Therapeutics Inc.Intraday Strategy with Real Time Monitoring - Newser
Applying Wyckoff theory to Coya Therapeutics Inc. stockFree AI Screening for Swing Trade Picks - Newser
Is Coya Therapeutics Inc. stock overvalued or undervaluedTop Growth Forecasts Backed By Experts - Jammu Links News
Price action breakdown for Coya Therapeutics Inc.Free Fundamental Winners With Safe Entry Plan - Newser
Published on: 2025-07-31 11:13:46 - metal.it
Published on: 2025-07-30 21:39:20 - Newser
Merck to discontinue drug from Pandion deal; Coya’s IND for ALS drug is delayed - Endpoints News
Buy Signal for Coya Therapeutics Inc. Stock Key Technical Indicators to WatchROI Focused Setup With Drawdown Analysis - Newser
Coya Therapeutics IncFDA unable to meet review goal date for Coya's IND for phase 2 ALS studySEC filing - MarketScreener
Coya Therapeutics, Inc. Announces Update on Investigational New Drug Application - MarketScreener
How Resilient Is Coya Therapeutics Inc. Stock During Economic DownturnsDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
What makes Coya Therapeutics Inc. stock price move sharplyFree Weekly Return Pick Forecast Reports - Newser
What is Coya Therapeutics Inc. company’s growth strategyStock Strategy Insights For Consistent Profits - Jammu Links News
Coya Therapeutics Inc. Stock Performance After Earnings: Historical Insights3-Year Equity Summary With Setup Insights - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attention Sector Rotation and Stock Opportunity Analysis - Newser
How volatile is Coya Therapeutics Inc. stock compared to the marketDiscover high-impact stocks for growth - Jammu Links News
How does Coya Therapeutics Inc. compare to its industry peersStrong return on assets - Jammu Links News
Coya Therapeutics Inc (COYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):